| |
 |
|
Class Information
Number: 514/4
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai > Insulin or derivative > With an additional active ingredient
Description: Subject matter which contains insulin and an additional active ingredient.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6565885 |
Methods of spray drying pharmaceutical compositions |
May. 20, 2003 |
| 6559122 |
Formulated composition |
May. 6, 2003 |
| 6551989 |
Preventing airway mucus production by administration of EGF-R antagonists |
Apr. 22, 2003 |
| 6551992 |
Stable insulin formulations |
Apr. 22, 2003 |
| 6548049 |
Medicinal aerosol formulation |
Apr. 15, 2003 |
| 6544946 |
Inhibitors for use in hemostasis and immune function |
Apr. 8, 2003 |
| 6540982 |
Medical aerosol formulation |
Apr. 1, 2003 |
| 6540983 |
Medical aerosol formulation |
Apr. 1, 2003 |
| 6531448 |
Insoluble compositions for controlling blood glucose |
Mar. 11, 2003 |
| 6531112 |
Formulations for administering calcitonin and processes for preparing the same |
Mar. 11, 2003 |
| 6528481 |
NG2/HM proteoglycan-binding peptides that home to angiogenic vasculature and related methods |
Mar. 4, 2003 |
| 6514937 |
Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3 |
Feb. 4, 2003 |
| 6506724 |
Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus |
Jan. 14, 2003 |
| 6495515 |
Chemokine binding protein and methods of use therefor |
Dec. 17, 2002 |
| 6495120 |
Formulation and system for intra-oral delivery of pharmaceutical agents |
Dec. 17, 2002 |
| 6489292 |
Stable aqueous insulin preparations without phenol and cresol |
Dec. 3, 2002 |
| 6468963 |
Methods and formulations for reducing toxicity associated with diabetes treatments |
Oct. 22, 2002 |
| 6468507 |
Non-aqueous aerosol formulation comprising rosiglitazone maleate, a non-aqueous carrier, and an amino acid stabilizer |
Oct. 22, 2002 |
| 6464959 |
Non-aqueous aerosol suspension comprising troglitazone, a fluid propellant, and an amino acid stabilizer |
Oct. 15, 2002 |
| 6465426 |
Insoluble insulin compositions |
Oct. 15, 2002 |
| 6451762 |
Aggregates of human insulin derivatives |
Sep. 17, 2002 |
| 6447766 |
Method of mobilizing hematopoietic stem cells |
Sep. 10, 2002 |
| 6448221 |
Methods of promoting blood flow within the vasculature of a mammal |
Sep. 10, 2002 |
| 6436367 |
Aerosol formulations for buccal and pulmonary application |
Aug. 20, 2002 |
| 6432383 |
Method for administering insulin |
Aug. 13, 2002 |
| 6417164 |
Treatment of type II diabetes mellitus with amylin agonists |
Jul. 9, 2002 |
| 6410511 |
Formulations for amylin agonist peptides |
Jun. 25, 2002 |
| 6355276 |
Adhesive drug delivery composition |
Mar. 12, 2002 |
| 6333031 |
Receptor derived peptides as modulators of receptor activity |
Dec. 25, 2001 |
| 6329337 |
Adhesive for biological tissue |
Dec. 11, 2001 |
| 6326154 |
Ligand-mediated immunofunctional hormone binding protein assay method |
Dec. 4, 2001 |
| 6315978 |
Bioconjugates and delivery of bioactive agents |
Nov. 13, 2001 |
| 6310040 |
Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs |
Oct. 30, 2001 |
| 6310038 |
Pulmonary insulin crystals |
Oct. 30, 2001 |
| 6306440 |
Therapeutic preparation for inhalation |
Oct. 23, 2001 |
| 6274549 |
Treatment of type 1 diabetes |
Aug. 14, 2001 |
| 6271200 |
Proteinic drug delivery system using aerosolized membrane-mimetic amphiphiles |
Aug. 7, 2001 |
| 6268335 |
Insoluble insulin compositions |
Jul. 31, 2001 |
| 6221837 |
Insulin derivatives with increased zinc binding |
Apr. 24, 2001 |
| 6211144 |
Stable concentrated insulin preparations for pulmonary delivery |
Apr. 3, 2001 |
| 6207159 |
Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus |
Mar. 27, 2001 |
| 6174856 |
Stabilized insulin compositions |
Jan. 16, 2001 |
| 6169071 |
Compounds and methods for modulating cell adhesion |
Jan. 2, 2001 |
| 6165976 |
Therapeutic preparation for inhalation |
Dec. 26, 2000 |
| 6153200 |
Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
Nov. 28, 2000 |
| 6143718 |
Treatment of Type II diabetes mellutis with amylin agonists |
Nov. 7, 2000 |
| 6136784 |
Amylin agonist pharmaceutical compositions containing insulin |
Oct. 24, 2000 |
| 6127334 |
Methods for producing biphasic insulin formulations |
Oct. 3, 2000 |
| 6042824 |
Methods using cross linked protein crystal formulations as catalysts in organic solvents |
Mar. 28, 2000 |
| 6043214 |
Method for producing powder formulation comprising an insulin |
Mar. 28, 2000 |
|
|
|
